OPR - Delayed Quote • USD VIR Oct 2024 20.000 call (VIR241018C00020000) Follow 0.1000 0.0000 (0.00%) As of April 22 at 9:59 AM EDT. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for VIR241018C00020000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: VIR What Makes Vir Biotechnology (VIR) a New Buy Stock Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024 Vir Biotechnology Inc CEO Backer De Sells 72,995 Shares From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule Q4 2023 Vir Biotechnology Inc Earnings Call Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript Wall Street Analysts Believe Vir Biotechnology, Inc. (VIR) Could Rally 186.41%: Here's is How to Trade Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Tops Revenue Estimates
